METHODS OF PRODUCING T CELL POPULATIONS USING P38 MAPK INHIBITORS
US Application 19/079,743
Filed on 2025-03-14
Filed on 2025-03-14
Directed Acetylation of mRNA Through Engineered snoRNA Adapters
US Application 19/116,059
Filed on 2025-03-27
Filed on 2025-03-27
METHODS OF DETECTING LOSS OF HETEROZYGOSITY AND DAMAGING MUTATIONS IN
IMMUNE-RELATED GENES IN LIQUID BIOPSIES
Patent Cooperation Treaty
PCT/US2025/022568
Filed on 2025-04-01
PCT/US2025/022568
Filed on 2025-04-01
Chimeric Antigen Receptors Containing Glypican 2 Binding Domains
China
202510075685.4
Filed on 2025-01-17
202510075685.4
Filed on 2025-01-17
ANTI-KRAS-G12D T CELL RECEPTORS
Japan
2025-036871
Filed on 2025-03-07
2025-036871
Filed on 2025-03-07
RADIOLABELED GLYPICAN-3 (GPC3)-SPECIFIC SINGLE DOMAIN ANTIBODY AND USE THEREOF AS AN IMAGING AGENT FOR DETECTION OF GPC3-POSITIVE TUMORS
Patent Cooperation Treaty
PCT/US2025/021789
Filed on 2025-03-27
PCT/US2025/021789
Filed on 2025-03-27
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
China
202510245856.3
Filed on 2025-03-04
202510245856.3
Filed on 2025-03-04
BETA-CATENIN INHIBITORS AND DEGRADERS
US Application 63/742,947
Filed on 2025-01-08
Filed on 2025-01-08
Glypican 2 As A Cancer Marker And Therapeutic Target
Austria
16864859.0
Filed on 2018-05-18
16864859.0
Filed on 2018-05-18
TREATMENT OF CARDIOVASCULAR DISEASE WITH TEM8 ANTIBODIES
Patent Cooperation Treaty
PCT/US2025/017061
Filed on 2025-02-24
PCT/US2025/017061
Filed on 2025-02-24